Oxurion NV (GB:0G99) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Oxurion NV, a Belgian biopharmaceutical company specializing in ophthalmological therapies, reported receiving a transparency notification from Atlas Special Opportunities LLC. Atlas Special Opportunities LLC informed Oxurion that as of June 7, 2024, their shareholding fell below the 15% threshold, owning 1,785,024,954 of the total 12,275,690,851 outstanding shares after selling voting rights-bearing securities.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.
